Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
CALL
Newmont
NEM
$139B
| $6.55M | 0.01% |
70,100
+13,100
| +23% | +$1.43M |
|
1202
CALL
W.W. Grainger
GWW
$61.8B
| $6.53M | 0.01% |
4,800
-500
| -9% | -$616K |
|
1203
Alector
ALEC
$264M
| $6.53M | 0.01% |
3,247,426
+312,173
| +11% | +$669K |
|
1204
Northrop Grumman
NOC
$78.3B
| $6.51M | 0.01% |
12,776
+10,987
| +614% | +$6.34M |
|
1205
Amgen
AMGN
$238B
| $6.5M | 0.01% |
17,944
+9,964
| +125% | +$3.41M |
|
1206
Innoviva
INVA
$1.52B
| $6.49M | 0.01% |
285,610
-36,399
| -11% | -$833K |
|
1207
CALL
Shell
SHEL
$257B
| $6.46M | 0.01% |
83,300
+72,700
| +686% | +$6.28M |
|
1208
Restaurant Brands International
QSR
$28.2B
| $6.46M | 0.01% |
+89,046
| New | +$6.78M |
|
1209
Verastem
VSTM
$624M
| $6.44M | 0.01% |
1,686,575
+1,276,796
| +312% | +$6.18M |
|
1210
CALL
ConocoPhillips
COP
$162B
| $6.44M | 0.01% |
61,900
-58,900
| -49% | -$6.98M |
|
1211
Coinbase
COIN
$49.2B
| $6.43M | 0.01% |
43,970
+40,641
| +1,221% | +$7.34M |
|
1212
Yelp
YELP
$1.27B
| $6.4M | 0.01% |
261,097
-56,921
| -18% | -$1.42M |
|
1213
The Greenbrier Companies
GBX
$1.42B
| $6.4M | 0.01% |
130,605
-286,856
| -69% | -$14.1M |
|
1214
Brady Corp
BRC
$4.3B
| $6.39M | 0.01% |
+69,731
| New | +$5.8M |
|
1215
Arcutis Biotherapeutics
ARQT
$3.15B
| $6.37M | 0.01% |
+243,119
| New | +$5.66M |
|
1216
PUT
Halliburton
HAL
$29.4B
| $6.37M | 0.01% |
187,600
+15,700
| +9% | +$613K |
|
1217
PUT
Altria Group
MO
$110B
| $6.35M | 0.01% |
88,300
-104,500
| -54% | -$7.29M |
|
1218
HDFC Bank
HDB
$121B
| $6.33M | 0.01% |
245,162
+160,631
| +190% | +$4.03M |
|
1219
Kirby Corp
KEX
$7.39B
| $6.31M | 0.01% |
46,373
-72,133
| -61% | -$10.3M |
|
1220
RE/MAX Holdings
RMAX
$290M
| $6.3M | 0.01% |
+638,745
| New | +$5.57M |
|
1221
Citigroup
C
$221B
| $6.27M | 0.01% |
44,764
-2,066,041
| -98% | -$269M |
|
1222
Kinross Gold
KGC
$38.9B
| $6.26M | 0.01% |
265,084
+139,416
| +111% | +$4.1M |
|
1223
Remitly
RELY
$5.65B
| $6.26M | 0.01% |
279,224
-1,207,926
| -81% | -$24.8M |
|
1224
CALL
Apollo Global Management
APO
$78.4B
| $6.22M | 0.01% |
52,600
+44,500
| +549% | +$5.6M |
|
1225
CALL
Shopify
SHOP
$192B
| $6.22M | 0.01% |
54,500
+11,800
| +28% | +$1.35M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.